Genmab — August 2020
-
BGBIO's AXL-hæmmer klarer endpoint i fase 2 forsøg https://newsweb.oslobors.no/message/511488
-
Er det her noget af Genmabs? https://www.bt.dk/samfund/benni-faar-ny-banebrydende-kraeftbehandling-hallo-jeg-skal-ikke-doe-endnu
-
-
Dejlig artikel, tak for den butterboy
-
GEN1044 (DuoBody
-CD3x5T4) started recruiting in July https://www.clinicaltrials.gov/ct2/history/NCT04424641?A=1&B=2&C=merged#StudyPageTop -
GEN1046 still steadily adding locations, all recruiting https://www.clinicaltrials.gov/ct2/history/NCT03917381?A=9&B=10&C=merged#StudyPageTop
-
Enapotamab almost all recruiting as well https://www.clinicaltrials.gov/ct2/history/NCT02988817?A=16&B=17&C=merged#StudyPageTop
-
Mht epcoritamab, så tåler denne genlæsning. “Jeg har aldrig set så potent et lægemiddel til den her type patienter“ og “ lige så effektiv som CART-T og mere sikker” https://haematologisktidsskrift.dk/sygdomme/lymfoma/720-subkutant-bispecifikt-cd3-cd20-antistof-mulig-konkurrent-til-car-t.html
-
puha Darvin det er jo NSFW materiale du deler der

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind